Sir, Cholinergic urticaria is a relatively rare variant of physical urticaria that is characterized by pinpoint highly pruritic wheals caused by an increase in core body temperature. 1 Despite being first described many years ago, its epidemiology and various clinical characteristics remain elusive. A relative scarcity of reports regarding cholinergic urticaria from India intrigued us to evaluate its prevalence and clinical characteristics among our urticaria patients.
All the patients were routinely counseled regarding lifestyle modifications to avoid sweating. Fourteen patients were prescribed levocetirizine 5 mg and the remaining desloratadine 5 mg. On follow-up, at the end of 1 and 3 months, respectively, it was observed that all patients on desloratadine demonstrated a better symptomatic relief compared to levocetirizine. Subsequently, all the patients on levocetirizine were shifted to desloratadine. Ten patients responded to once-daily doses of desloratadine, while the remaining required dose escalation to 2-4 times a day for complete symptomatic relief.
Follow-up of patients in our study ranged between 3 and 5 years. Twenty-six (86.6%) patients on desloratadine were lesion free by 3 months of regular treatment and later required only occasional doses (once in a fortnight to once a month) along with avoidance of excessive sweating. The remaining four patients required more frequent doses of antihistamines. No particular risk factor could be identified in such patients.
The characteristic small and pruritic wheals in cholinergic urticaria appear following any stimulus that induces sweating, including elevation of body temperature, physical exercise, intake of spicy food and emotional stress. Cholinergic urticaria has been found to account for 30% of inducible urticaria and around 5%-7% of total urticaria cases in previous srudies. 2 However, in our study, its prevalence was only 1.7%, similar to an Indian study by Godse et al., who also found a lower prevalence of 4.16%. 3 Majority (9/30; 47%) of our patients were in their second decade of life or had an onset of disease in the second decade (13;68.7%).This is in concordance with previous reports, wherein a prevalence of 11% was noted in young adults and adolescents with up to 80% patients reporting onset of disease in adolescence. 4, 5 The mean duration of illness in our patients was 46 months, similar to that observed by Kim et al. 5 and Silpa-archa et al. 6 who reported that half of their patients achieved remission by 5 years from the onset of illness. However, one of our patients had cholinergic urticaria for 15 years which is exceptional.
A male predominance, as in our study, was also observed by Kim et al., 5 however, a female predominance was demonstrated by Zuberier et al. 4 As in previous studies, we observed seasonal variation in symptomatology in 22 (73.4%) cases. 5, 7 A previous study by Ramam et al., had also found symptoms limited to winter months (from October to January) in 62.5% patients, with 12.5% patients having increased frequency and severity of episodes during winters. 7 In our study, coexistent atopy was found in six (20%) patients only. Although some earlier studies mention a higher prevalence of atopy in such patients, it has been speculated that this higher association could be misleading as symptoms of itching and stinging experienced by atopics on exposure to hot water baths could have been misinterpreted as cholinergic urticaria. Thus, this association needs further confirmation. Table 2 summarizes the results of various studies on cholinergic urticaria.
Cholinergic urticaria can be severely disabling at times as most provoking factors are integral to daily activities. Performing appropriate provocation tests to establish its etiology can be greatly rewarding. This study highlights that the prevalence of cholinergic urticaria in India is lesser as compared to western countries. Whether this is due to genetic constitution, environmental factors or less frequent reporting to a health-care setup due to easy availability of over-the-counter antihistamines needs further studies. Furthermore, it remains to be studied if desloratadine has an additional influence on sweating or sweat sensitivity that could probably explain its better efficacy in controlling cholinergic urticaria.
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